Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.
Kuck
N A
NA
American Cyanamid Company, Medical Research Division, Lederle Laboratories, Pearl River, N.Y., USA.
Petersen
P J
PJ
Weiss
W J
WJ
Jacobus
N V
NV
Testa
R T
RT
Tally
F P
FP
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy; D004195:Disease Models, Animal; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005750:Gastric Juice; D006863:Hydrogen-Ion Concentration; D051379:Mice; D008826:Microbial Sensitivity Tests; D009077:Mucins; D010397:Penicillanic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D010878:Piperacillin / Q000494:pharmacology* / Q000627:therapeutic use; D013552:Swine; D000078142:Tazobactam
D000900:Anti-Bacterial Agents; D009077:Mucins; D010397:Penicillanic Acid; D000078142:Tazobactam; D010878:Piperacillin